Calendar TME Pharma N.V.

Equities

Market Closed - Euronext Paris Other stock markets 11:35:22 2024-04-26 EDT			5-day change	1st Jan Change
0.249 ^EUR	+0.20%		-0.99%	+8.26%

04-25	TME Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-23	TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer	CI

84a40c38.RyHbD3gKNcXa1Ui7oxIj01ftgGE5mQyJ83OdVpSbHds.N02JYhV6d6iXkz6C51tZjByM9xJ7rW_9gALyOuyqXKIubpdaGl9q8JCjPw~4e6b2f18397959eab75a9600e2ac08ce

2024-10-23	Q2 2024 Earnings Release (Projected)
2025-04-22	Q4 2024 Earnings Release (Projected)
2025-10-22	Q2 2025 Earnings Release (Projected)
2026-04-28	Q4 2025 Earnings Release (Projected)

2024-04-25 12:00	Q4 2023 Earnings Release
2024-03-25	Glioblastoma Development Summit
2024-03-17	Bio Europe Spring Conference
2023-11-17 22:30	Society for Neuro Oncology Meeting
2023-10-27 12:00	Q2 2023 Earnings Release
2023-10-21 05:15	European Society for Medical Oncology Congress
2023-06-29 07:30	Annual General Meeting
2023-06-03 14:15	American Society of Clinical Oncology Conference - abstract #2048
2023-06-01	American Society of Clinical Oncology Conference
2023-04-24 12:00	Q4 2022 Earnings Release
2023-01-30 07:30	Extraordinary Shareholders Meeting
2022-11-22 12:00	Investor Meeting - Key Opinion Leader
2022-11-18 19:30	Society for Neuro-Oncology Meeting - Abstract No: CTNI-67
2022-10-26 13:00	Interim 2022 Earnings Release
2022-10-23	BIO Europe Conference
2022-09-20	Sachs Associates Biotech in Europe Forum
2022-09-08	ESMO Congress Conference
2022-06-29 08:00	Annual General Meeting
2022-06-10 08:00	Investor Meeting - Key Opinion Leader
2022-06-02	American Society of Clinical Oncology Meeting

Fiscal Period	December	2019	2020	2021	2022
Net sales Million EUR	Released Forecast Spread	0,00 0,00 -	0,00	0,00 6,60 -	0,03 0,10 -66%
EBITDA Million EUR	Released Forecast Spread	-3,90 -4,95 21.19%	0,00	-13,2 -5,20 -153.87%	-11,9 -16,3 26.77%
EBIT Million EUR	Released Forecast Spread	-3,95 -5,05 21.82%	0,00	-13,3 -5,30 -150.32%	-12,0 -16,3 26.2%
Earnings before Tax (EBT)	Released Forecast Spread	0,00 0,00 -	0,00	0,00 0,00 -	0,00 0,00 -
Net income Million EUR	Released Forecast Spread	-0,86 -5,50 84.35%	-10,4	0,00 0,00 -	0,00 0,00 -
EPS EUR	Released Forecast Spread	0,00 0,00 -	-32,0	0,00 0,00 -	0,00 0,00 -
Announcement Date		22/04/20	28/04/21	22/04/22	24/04/23

2024-04-28	BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28	SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
2024-04-28	JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
2024-04-28	MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-29 16:05	QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29	CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-30	DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	AZENTA, INC.: Q2 2024 Earnings Release (Projected)

2024-04-26	GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
2024-04-26	GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-26 01:00	BB BIOTECH AG: Q1 2024 Earnings Release
2024-04-25	BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25	PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
2024-04-25	HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
2024-04-25	BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
2024-04-25	CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 07:00	MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
2024-04-25 02:00	PURETECH HEALTH PLC: Q4 2023 Earnings Release